|
Cabling Services
|
AUG1700038421
|
$16,211
|
$16,211
|
N/A
|
N/A
|
|
ACM17001-001-00000
|
ACM17001
|
$38,000
|
$38,000
|
UNKNOWN, UNKNOWN
|
|
|
ACO13015-001-01002
|
ACO13015
|
$11,862
|
$11,862
|
UNKNOWN, UNKNOWN
|
|
|
Noninvasive Contrast Enhanced Early Detection of Melanoma Liver Metastasis
|
2R42CA183376-02X1
|
$46,492
|
$46,492
|
Yang
|
"INLIGHTA BIOSCIENCES, LLC"
|
|
Development of Tumor Proliferation PET Tracer FLT using a Low Cost Single Dose Automatic Production and Quality Control Biomarker Generator System
|
5R44CA195831-03
|
$711,781
|
$711,781
|
Bruckbauer, Thomas
|
ABT MOLECULAR IMAGING, INC.
|
|
OPTION YEAR 1 - PILOT TESTING A HEALTHCARE DELIVERY RESEARCH FELLOWSHIP PROGRAM (TASK 4) AS STATED IN THE SOW
|
261201600638P
|
$38,294
|
$38,294
|
UNKNOWN, UNKNOWN
|
ACADEMYHEALTH
|
|
IeDEA West Africa Renewal 3
|
U01AI069919-12
|
$225,000
|
$225,000
|
Dabis, Francois
|
ADERA
|
|
Modulation of Immune Checkpoints by Self-Deliverable RNAi for Adoptive Cell Transfer
|
1R43CA213632-01
|
$231,500
|
$231,500
|
WOLFSON, ALEXEY
|
ADVANCED RNA TECHNOLOGIES, LLC
|
|
Device Strategy for Selective Isolation of Oncosomes and Non-Malignant Exosomes
|
261201700022C*1
|
$299,250
|
$299,250
|
N/A
|
AETHLON MEDICAL, INC.
|
|
Peptide-based tool for the rapid isolation of quiescent monocytes from peripheral blood
|
1R43CA211061-01A1
|
$308,839
|
$308,839
|
DARBY, MARTYN
|
AFFINERGY, LLC
|
|
Women's Interagency HIV Study (WIHS-V)
|
U01AI035004-25
|
$144,370
|
$144,370
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, IN
|
|
Central Africa International Epidemiologic Database to Evaluate AIDS
|
U01AI096299-08
|
$260,000
|
$260,000
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, IN
|
|
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048349-25
|
$68,181
|
$68,181
|
CRANDALL, JILL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, IN
|
|
Einstein-Rockefeller-CUNY Center for AIDS Research
|
P30AI124414-01A1
|
$174,258
|
$174,258
|
GOLDSTEIN, HARRIS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, IN
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-04
|
$701,778
|
$701,778
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The sequence recognition, structure and function of the IMP family of mRNA binding proteins
|
1F30CA214009-01A1
|
$49,044
|
$49,044
|
BISWAS, JEETAYU
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Building Research Capacity to Address the Challenge of Non Communicable Diseases and Injuries in Rwanda The GUKORANA Research Center
|
1P20CA210284-01A1
|
$340,631
|
$340,631
|
CASTLE, PHILIP
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Molecular analysis and therapeutic targeting of PI3K signaling in thyroid cancer
|
5R01CA128943-09
|
$396,625
|
$396,625
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
PI3K-mediated metabolic alterations in the pre-neoplastic thyroid
|
5R01CA167839-06
|
$346,525
|
$346,525
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
PI3K Isoform Dependence in Adult Hematopoiesis and Myeloid Leukemia
|
5R01CA196973-02
|
$409,153
|
$409,153
|
GRITSMAN, KIRA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Epigenetic activity of normal and cancer-associated mutant H1 linker histones
|
5F30CA210539-02
|
$44,044
|
$44,044
|
HEALTON, SEAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Paul Calabresi Career Development Award for Clinical Oncology (K12)
|
5K12CA132783-09
|
$810,000
|
$810,000
|
PEREZ-SOLER, ROMAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Methylthioadenosine Phosphorylase and AdoMet Synthetase in Cancer
|
5R01CA135405-10
|
$290,592
|
$290,592
|
SCHRAMM, VERN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Optimization of Non-Ablative Focused Ultrasound Therapy for Tumor Immunity
|
5F30CA200411-04
|
$49,044
|
$49,044
|
SKALINA, KARIN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Methylome characterization of bronchial epithelial projenitor cells
|
1R21CA209436-01A1
|
$216,172
|
$216,172
|
SPIVACK, SIMON
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Mechanisms of Formation and Progression of Preleukemic Stem Cells
|
1R01CA217092-01
|
$397,371
|
$397,371
|
STEIDL, ULRICH
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia
|
5R01CA166429-06
|
$384,342
|
$384,342
|
STEIDL, ULRICH
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Contributions of sympathetic signals to prostate cancer progression.
|
5F30CA203446-02
|
$49,044
|
$49,044
|
ZAHALKA, ALI
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
|
261201700020C
|
$125,000
|
$125,000
|
DENYSENKO, SERGIY
|
ALCHEM LABORATORIES CORPORATION
|
|
SYNTHESIS OF NON-GMP SMALL MOLECULES FOR DRUG DISCOVERY. HHSN261201200012C; DTP-17-003; ALCHEM LABORATORIES, INC.; DSCB; PROJECT MC1-1; TO#19; WA NX232-107-165-004; CAN# 8487300; NEXT
|
261201200012C
|
$412,782
|
$412,782
|
UNKNOWN, UNKNOWN
|
ALCHEM LABORATORIES CORPORATION
|
|
NEXT TRIAPINE NX007-110-186-001 - PREPARE 500 GM OF TRIAPINE, DTP17-004, HHSN261201200020C
|
261201200020C
|
$381,725
|
$381,725
|
UNKNOWN, UNKNOWN
|
ALCHEM LABORATORIES CORPORATION
|
|
OPTION PERIOD ONE
|
261201600066C
|
$535,826
|
$535,826
|
UNKNOWN, UNKNOWN
|
ALCHEM LABORATORIES CORPORATION
|
|
SYNTHESIS OF NON-GMP MOLECULES; TO 1 CLIN2 $912.54 (REMAINING MIN. GUARANTEE AMT); HHSN261201700007I ALCHEM LABS; DTP-17-049; CAN 8487300 NEXT; FUNDING PERIOD 9/11/17-9/10/18
|
261201700007I
|
$1,000
|
$1,000
|
UNKNOWN, UNKNOWN
|
ALCHEM LABORATORIES CORPORATION
|
|
Novel IL-15 Superagonist Therapy for Bladder Cancer
|
2R44CA156740-04
|
$999,919
|
$999,919
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
Molecular Biology in Clinical Oncology Workshop
|
5R25CA057732-25
|
$249,978
|
$249,978
|
SAWYERS, CHARLES
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Methods in Clinical Cancer Research Workshop
|
5R25CA068647-20
|
$224,999
|
$224,999
|
VON HOFF, DANIEL
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Imaging and Radiation Oncology Core (IROC) Group
|
5U24CA180803-04
|
$8,214,381
|
$8,214,381
|
FOLLOWILL, DAVID
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
AMERICAN S FOR NONSMOKERS RIGHTS SMOKEFREE ORDINANCES DATA -- CATALOG # : 1
|
261201700689P
|
$16,550
|
$16,550
|
UNKNOWN, UNKNOWN
|
AMERICAN NONSMOKERS RIGH
|
|
Young Investigator travel support for the 2016 through 2020 APS Annual Scientific
|
R13AT009161-02
|
$5,000
|
$5,000
|
Price, Theodore
|
AMERICAN PAIN SOCIETY
|
|
Training and Mentorship of Hematologic Oncologists
|
5R25CA168526-05
|
$239,326
|
$239,326
|
MIKHAEL, JOSEPH
|
AMERICAN SOCIETY OF HEMATOLOGY
|
|
2017 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA217139-01
|
$7,000
|
$7,000
|
MITCHELL, RICHARD
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
|
RAID AMIN- ADDING ENVIROMENTAL POLLUTION DATA TO CANCER SURVEILLANCE DATABASES, POP 9/1/17-8/31/18
|
261201700458P
|
$25,000
|
$25,000
|
UNKNOWN, UNKNOWN
|
AMIN, RAID
|
|
Clinical Trial of ABC294640 in Patients with Refractory Multiple Myeloma
|
5R44CA199767-03
|
$653,219
|
$653,219
|
SMITH, CHARLES
|
APOGEE BIOTECHNOLOGY CORPORATION
|
|
Rapid Point of Care Detection of HPV-Associated Malignancies
|
1UG3CA211415-01
|
$375,888
|
$375,888
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Single Cell Technologies for Rapid Detection of Tumor Heterogeneity
|
5R21CA196460-03
|
$204,524
|
$204,524
|
ANDERSON, KAREN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Quantification of Circulating Antigens for Pediatric TB Diagnosis andTreatment Mo
|
R01AI122932-03
|
$20,693
|
$20,693
|
Hu, Ye
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Investigation of Biomarkers for Sugars Intake - A Controlled Feeding Study
|
5R01CA197902-03
|
$563,736
|
$563,736
|
TASEVSKA, NATASHA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
NCI, Division of Cancer Prevention Protocol Information Office Support
|
261201000044C
|
$600,000
|
$600,000
|
BRYANT-DAVIS, WANDA
|
ARSERVICES, LTD
|
|
APPLICATION SUPPORT - YEAR 3
|
261201500033I
|
$900,185
|
$900,185
|
UNKNOWN, UNKNOWN
|
ARTIFICIAL INTELLIGENCE IN MEDICINE, INC
|
|
Interferon-gamma limits the effectiveness of peptide vaccines for cancer
|
5R01CA157303-06
|
$294,616
|
$294,616
|
CELIS, ESTEBAN
|
AUGUSTA UNIVERSITY
|
Total relevant funding to Cancer for this search: $1,985,303,439
|